Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides
暂无分享,去创建一个
[1] C. Supuran. Advances in structure-based drug discovery of carbonic anhydrase inhibitors , 2017, Expert opinion on drug discovery.
[2] T. Tunç,et al. A novel proton transfer salt of 2-amino-6-sulfamoylbenzothiazole and its metal complexes: the evaluation of their inhibition effects on human cytosolic carbonic anhydrases , 2017, Journal of enzyme inhibition and medicinal chemistry.
[3] C. Supuran,et al. Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations. , 2016, Journal of medicinal chemistry.
[4] C. Supuran,et al. Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors , 2016, Journal of enzyme inhibition and medicinal chemistry.
[5] C. Supuran,et al. Multicomponent chemistry in the synthesis of carbonic anhydrase inhibitors , 2016, Journal of enzyme inhibition and medicinal chemistry.
[6] C. Supuran,et al. Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases , 2016, Journal of enzyme inhibition and medicinal chemistry.
[7] C. Supuran,et al. Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium , 2016, Journal of enzyme inhibition and medicinal chemistry.
[8] S. Carradori,et al. Microwave-assisted extraction, HPLC analysis, and inhibitory effects on carbonic anhydrase I, II, VA, and VII isoforms of 14 blueberry Italian cultivars , 2016, Journal of enzyme inhibition and medicinal chemistry.
[9] I. Gulcin,et al. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides , 2016, Journal of enzyme inhibition and medicinal chemistry.
[10] C. Supuran. Structure and function of carbonic anhydrases. , 2016, The Biochemical journal.
[11] C. B. Mishra,et al. Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors , 2016, Journal of enzyme inhibition and medicinal chemistry.
[12] C. Supuran. Carbonic anhydrase inhibition and the management of neuropathic pain , 2016, Expert review of neurotherapeutics.
[13] C. Supuran,et al. A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents , 2016, Journal of enzyme inhibition and medicinal chemistry.
[14] C. Supuran,et al. Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases , 2016, Journal of enzyme inhibition and medicinal chemistry.
[15] C. Supuran. How many carbonic anhydrase inhibition mechanisms exist? , 2016, Journal of enzyme inhibition and medicinal chemistry.
[16] C. Supuran,et al. Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells , 2016, Journal of enzyme inhibition and medicinal chemistry.
[17] C. Supuran. Acetazolamide for the treatment of idiopathic intracranial hypertension , 2015, Expert review of neurotherapeutics.
[18] C. Supuran,et al. Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis , 2015, Journal of enzyme inhibition and medicinal chemistry.
[19] C. Supuran,et al. A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects. , 2015, Bioorganic & medicinal chemistry.
[20] C. Supuran,et al. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors , 2015, Journal of enzyme inhibition and medicinal chemistry.
[21] C. Supuran,et al. An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? , 2015, Journal of enzyme inhibition and medicinal chemistry.
[22] C. Supuran,et al. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases. , 2014, Bioorganic & medicinal chemistry letters.
[23] C. Supuran,et al. Sulfa and trimethoprim-like drugs – antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors , 2014, Journal of enzyme inhibition and medicinal chemistry.
[24] C. Supuran,et al. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors , 2013, Expert opinion on drug discovery.
[25] C. Supuran,et al. Anticancer carbonic anhydrase inhibitors: a patent review (2008 – 2013) , 2013, Expert opinion on therapeutic patents.
[26] Andrea Scozzafava,et al. Antiobesity carbonic anhydrase inhibitors: a literature and patent review , 2013, Expert opinion on therapeutic patents.
[27] C. Supuran. Carbonic anhydrase inhibitors: an editorial , 2013, Expert opinion on therapeutic patents.
[28] C. Supuran,et al. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013) , 2013, Expert opinion on therapeutic patents.
[29] C. Supuran,et al. Antiglaucoma carbonic anhydrase inhibitors: a patent review , 2013, Expert opinion on therapeutic patents.
[30] C. Supuran. Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture , 2013, Journal of enzyme inhibition and medicinal chemistry.
[31] C. Supuran. Structure-based drug discovery of carbonic anhydrase inhibitors , 2012, Journal of enzyme inhibition and medicinal chemistry.
[32] C. Supuran,et al. Sulfonamides: a patent review (2008 – 2012) , 2012, Expert opinion on therapeutic patents.
[33] C. Supuran,et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? , 2012, Chemical reviews.
[34] C. Supuran. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity , 2012, Expert opinion on emerging drugs.
[35] C. Supuran,et al. Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. , 2012, Journal of medicinal chemistry.
[36] C. Supuran,et al. A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology , 2012, Journal of enzyme inhibition and medicinal chemistry.
[37] Claudiu T. Supuran,et al. Interfering with pH regulation in tumours as a therapeutic strategy , 2011, Nature Reviews Drug Discovery.
[38] C. Supuran,et al. In Vitro Inhibition of Human Carbonic Anhydrase I and II Isozymes with Natural Phenolic Compounds , 2011, Chemical biology & drug design.
[39] Vladimir Garaj,et al. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. , 2011, Bioorganic & medicinal chemistry.
[40] S. Leung,et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. , 2011, Cancer research.
[41] C. Supuran,et al. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. , 2011, Journal of medicinal chemistry.
[42] C. Supuran,et al. Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency. , 2010, Chemical communications.
[43] Claudiu T. Supuran,et al. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.
[44] C. Supuran,et al. Metal-Based Antibacterial and Antifungal Agents: Synthesis, Characterization, and In Vitro Biological Evaluation of Co(II), Cu(II), Ni(II), and Zn(II) Complexes With Amino Acid-Derived Compounds , 2006, Bioinorganic chemistry and applications.
[45] C. Supuran,et al. Therapeutic potential of sulfamides as enzyme inhibitors , 2006, Medicinal research reviews.
[46] Giuseppe Fasolis,et al. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. , 2005, Bioorganic & medicinal chemistry letters.
[47] C. Supuran,et al. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. , 2005, Bioorganic & medicinal chemistry letters.
[48] C. Supuran,et al. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties. , 2004, Bioorganic & medicinal chemistry letters.
[49] Andrea Scozzafava,et al. Carbonic anhydrase inhibitors. , 2001, Medicinal research reviews.
[50] Luca Menabuoni,et al. Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties. , 2002, Journal of medicinal chemistry.
[51] C. Supuran,et al. Unsymmetrical 1,1′-disubstituted Ferrocenes: Synthesis of Co(ii), Cu(ii), Ni(ii) and Zn(ii) Chelates of Ferrocenyl -1-thiadiazolo-1′-tetrazole, -1-thiadiazolo-1′-triazole and -1-tetrazolo-1′-triazole with Antimicrobial Properties , 2002, Journal of enzyme inhibition and medicinal chemistry.
[52] C. Supuran,et al. Bacterial proteases: current therapeutic use and future prospects for the development of new antibiotics , 2001 .
[53] A Casini,et al. Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects. , 2000, Journal of medicinal chemistry.
[54] C. Supuran,et al. Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action. , 2000, Journal of medicinal chemistry.
[55] C. Supuran,et al. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring? , 1999, Bioorganic & medicinal chemistry.
[56] C. Supuran,et al. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? , 1999, Journal of medicinal chemistry.
[57] C. Supuran,et al. Carbonic anhydrase inhibitors - Part 57 : Quantum chemical QSAR of a group of 1,3,4-thiadiazole- and 1,3,4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties , 1999 .
[58] C. Supuran,et al. Carbonic anhydrase inhibitors — Part 52. Metal complexes of heterocyclic sulfonamides: A new class of strong topical intraocular pressure-lowering agents in rabbits , 1998 .
[59] C. Supuran,et al. Carbonic anhydrase inhibitors - Part 49: Synthesis of substituted ureido and thioureido derivatives of aromatic/heterocyclic sulfonamides with increased affinities for isozyme I , 1998 .
[60] C. Supuran,et al. Carbonic Anhydrase Activators. Part 14. Syntheses of Mono- and Bis( pyridinium)salt Derivatives of 2-Amino-5-(2-aminoethyl)- and 2-Amino-5- (3-aminopropyl)-1,3,4-thiadiazole and Their Interaction with Isozyme II. , 1996 .
[61] C. Supuran,et al. Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes* , 1996 .
[62] C. Supuran,et al. Carbonic anhydrase inhibitors. Part 37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes# , 1996 .
[63] C. Supuran,et al. Carbonic anhydrase activators. 3: structure-activity correlations for a series of isozyme II activators. , 1994, Journal of pharmaceutical sciences.
[64] R. Khalifah,et al. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. , 1971, The Journal of biological chemistry.